top of page

Maryville

Public·22 members

sonu Pawar
sonu Pawar

US Insulin Delivery Devices Market on Steady Climb, Projected to Reach $8.1 Billion by 2034.

 

US Insulin Delivery Devices Market News

The US insulin delivery devices market is experiencing significant growth, driven by the rising prevalence of diabetes, technological advancements, and increasing adoption of user-friendly devices for self-management. Several market reports highlight this upward trend:

Market Size and Growth Projections:

  • The US insulin delivery devices market was estimated at USD 4.04 billion in 2023 and is projected to reach around USD 8.10 billion by 2034, exhibiting a CAGR of 7% during the forecast period (2024-2034).

  • Another report estimates the US market to reach USD 8,479.0 million by 2030, with a CAGR of 7.6% from 2024 to 2030.

  • A third source predicts the US market will reach over USD 19 billion by 2032, highlighting the substantial growth expected.

Key Growth Drivers:

  • Increasing Prevalence of Diabetes: The rising number of individuals diagnosed with both type 1 and type 2 diabetes in the US is a primary driver for market expansion.

  • Technological Advancements: Innovations in insulin delivery devices, such as the development of more convenient, efficient, and user-friendly options like insulin pens and pumps, are fueling market growth.

  • Growing Adoption of Minimally Invasive Methods: Patients and healthcare providers are increasingly favoring minimally invasive insulin delivery methods.

  • Home Healthcare Trend: The increasing preference for managing diabetes at home is boosting the demand for portable and easy-to-use insulin delivery devices.

  • Favorable Reimbursement Policies: Supportive reimbursement policies in the US are facilitating greater access to these devices.

  • Rising Awareness: Increased awareness among patients and healthcare professionals about the importance of proper insulin management and the availability of advanced 1 delivery devices is contributing to market growth.  

Key Market Trends and Innovations:

  • Insulin Pens Lead the Market: Insulin pens were the largest revenue-generating product segment in 2023 due to their user-friendly design and convenience.

  • Insulin Pumps are the Fastest Growing Segment: Insulin pumps, including both tethered and patch pumps, are anticipated to be the most lucrative and fastest-growing segment due to their ability to provide more precise and customizable insulin delivery.

  • Smart Insulin Pens: The emergence of "smart" insulin pens with connectivity features is gaining traction.

  • Artificial Pancreas Systems: The development and increasing adoption of automated insulin delivery (AID) systems, which integrate continuous glucose monitoring (CGM) with insulin pumps, are revolutionizing diabetes management. The FDA-approved OmniPod 5 HCL system, which integrates with Dexcom G6 CGM, is a prime example.

  • Focus on User Experience: Manufacturers are emphasizing ergonomic designs and features that enhance user comfort and ease of use.

  • e-Commerce Growth: The e-commerce channel is expected to witness significant growth in insulin delivery device sales due to its convenience and cost benefits.

Competitive Landscape:

The US insulin delivery devices market is competitive, with key players including:

  • Novo Nordisk A/S

  • Sanofi SA

  • Eli Lilly and Co

  • Medtronic PLC

  • Insulet Corporation

  • Tandem Diabetes Care

  • Abbott Laboratories

  • Roche

These companies are continuously innovating and forming partnerships to enhance their product offerings and market reach. For example, Abbott and Tandem Diabetes Care have partnered to integrate CGM with insulin pumps.

Challenges:

  • Cost of Devices and Consumables: The high cost of advanced insulin delivery devices and related supplies can be a barrier to adoption for some patients.

  • Reimbursement Issues: While policies are generally favorable, reimbursement complexities can still pose challenges.

Overall, the US insulin delivery devices market is poised for strong growth, driven by technological advancements, increasing diabetes prevalence, and a growing focus on patient-centric and convenient solutions for insulin management. The integration of CGM with insulin delivery systems and the development of smart devices are key trends shaping the future of this market.

 

1 View

About

Welcome to my group! Connect with other members, start disc...

Members

  • Elowen Morrison
    Elowen Morrison
  • brittaney
  • sonu Pawar
    sonu Pawar
  • Cheoni Kang
    Cheoni Kang
  • Sagar Shinde
    Sagar Shinde
bottom of page